1-4 of 4
Douglas W. Sborov, MD MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update

Peter M. Voorhees, MD, Jonathan L. Kaufman, MD, Jacob P. Laubach, MD, Douglas W. Sborov, MD MSc, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, MD, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, MD PhD, Nitya Nathwani, MD, Nina D. Shah, MD, Yvonne A. Efebera, MD MPH, Caitlin L. Costello, MD, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD, Robert Z. Orlowski, MD PhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, MD, Sean Murphy, Yana Lutska, PharmD, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Carla de Boer, Daniela Hoehn, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 691.
https://doi.org/10.1182/blood-2019-123465
Published: 2019
Journal Articles

Immunomodulatory Effects of HDACi in Combination with Checkpoint Blockade and Lenalidomide in the Immunosuppressive Multiple Myeloma Bone Marrow Microenvironment

Greg D Whitehill, BS, Alicia Chivers, MS, Bryan Danielson, PhD, Julien SR Tessier, MS, Gabriela Hernandez Duran, Gabrielle L Bender, BS, Douglas W. Sborov, MD MSc, Craig C Hofmeister, MDMPH, James Bradner, MD, Teru Hideshima, MD PhD, Kenneth C Anderson, MD, Gullu Gorgun, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4422.
https://doi.org/10.1182/blood.V130.Suppl_1.4422.4422
Published: 2017
Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma

Sabarinath Venniyil Radhakrishnan, MBBS, MD, Tim Luetkens, MD, Sara Yousef, PhD, Neelam Bhardwaj, PhD, Mary Nicole Steinbach, NP, Janet Weidner, Christa Shorter, BSc, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3142.
https://doi.org/10.1182/blood.V130.Suppl_1.3142.3142
Published: 2017
Journal Articles

"In Vivo Vaccination" Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab

Tim Luetkens, MD, Sara Yousef, PhD, Christa Shorter, BSc, Srinivas K. Tantravahi, MBBS, Mary Nicole Steinbach, NP, Janet Weidner, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1830.
https://doi.org/10.1182/blood.V130.Suppl_1.1830.1830
Published: 2017